Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
348.03
+1.16 (+0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about United Therapeutic
< Previous
1
2
3
4
5
6
Next >
Earnings Outlook For United Therapeutics
February 20, 2024
Via
Benzinga
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
February 12, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
January 25, 2024
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.
Via
InvestorPlace
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Via
InvestorPlace
United Therapeutics: A Strong Quarter But What About 2024?
August 15, 2023
United Therapeutics had strong Tyvaso sales but it highlights the investor debate heading into 2024.
Via
Talk Markets
What 4 Analyst Ratings Have To Say About United Therapeutics
August 03, 2023
Via
Benzinga
United Therapeutics's Return On Capital Employed Insights
May 10, 2023
Via
Benzinga
Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today?
December 20, 2023
Liquidia Corp (NASDAQ: LQDA) stock jumped after a win in a pat
Via
Benzinga
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Via
InvestorPlace
Flying Car Stocks: What a Devastating Short Report Means for EHang
November 08, 2023
Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch.
Via
InvestorPlace
EH Stock Alert: Hindenburg Slams EHang in New Short Report
November 07, 2023
EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm.
Via
InvestorPlace
Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical
October 30, 2023
Via
Benzinga
The Latest Analyst Ratings for United Therapeutics
May 04, 2023
Via
Benzinga
Why United Therapeutics Shares Are Falling Today
May 03, 2023
United Therapeutics Corporation's (NASDAQ: UTHR) Q1 revenues grew 10% Y/Y to $506.9 million, missing the
Via
Benzinga
Recap: United Therapeutics Q1 Earnings
May 03, 2023
Via
Benzinga
Analyst Expectations for United Therapeutics's Future
April 10, 2023
Via
Benzinga
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
This Foreboding Sign Looms Over United Therapeutics's Chart
April 05, 2023
Via
Benzinga
Why Is Life Sciences Company Miromatrix Medical Stock Trading Higher Today?
October 30, 2023
United Therapeutics Corporation (NASDAQ: UTHR) has agreed to acquire Miromatrix Medical Inc (NASDAQ: MIRO) for $3.25 per share in cash (an aggregate of approximately $91 million).
Via
Benzinga
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?
October 30, 2023
Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 30, 2023
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!
Via
InvestorPlace
Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023
September 20, 2023
Defensive stocks have always been the go-to investments for those looking to protect their long-term portfolio and weather downturns.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.
Via
InvestorPlace
Earnings Outlook For United Therapeutics
February 21, 2023
Via
Benzinga
Analyst Ratings for United Therapeutics
January 11, 2023
Via
Benzinga
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
July 26, 2023
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.
Via
InvestorPlace
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.
Via
InvestorPlace
Want To Copy 'Master Trader' Nancy Pelosi's Investments? There's An ETF For That. Here Are The Holdings
February 07, 2023
Subversive Capital launched two new ETFs Tuesday that offer investors the chance to mirror the trades being made by members of Congress.
Via
Benzinga
Earnings Scheduled For February 22, 2023
February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.